Showing items 1581-1630 of 2308 (47 Page(s) Totally)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-06-30T08:09:51Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T06:13:53Z |
Melioidosis: an emerging infection in Taiwan?
|
Hsueh P.R.;Lee-Jene Teng;Lee L.N.;Yu C.J.;Yang P.C.;Ho S.W.;Luh K.T.; Hsueh P.R.; LEE-JENE TENG; Lee L.N.; Yu C.J.; Yang P.C.; Ho S.W.; Luh K.T. |
| 臺大學術典藏 |
2020-06-30T06:13:49Z |
Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a University Hospital, Taiwan
|
Hsueh P.-R.;Lee-Jene Teng;Chen C.-Y.;Chen W.-H.;Yu C.-J.;Ho S.-W.;Luh K.-T.; Hsueh P.-R.; LEE-JENE TENG; Chen C.-Y.; Chen W.-H.; Yu C.-J.; Ho S.-W.; Luh K.-T. |
| 臺大學術典藏 |
2020-06-30T06:13:45Z |
Dissemination of a Clone of Unusual Phenotype of Pandrug-Resistant Acinetobacter baumannii at a University Hospital in Taiwan
|
Kuo L.-C.;Lee-Jene Teng;Yu C.-J.;Ho S.-W.;Hsueh P.-R.; Kuo L.-C.; LEE-JENE TENG; Yu C.-J.; Ho S.-W.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-06-30T06:13:34Z |
Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes
|
Tan C.-K.;Liaw S.-J.;Yu C.-J.;Lee-Jene Teng;Hsueh P.-R.; Tan C.-K.; Liaw S.-J.; Yu C.-J.; LEE-JENE TENG; Hsueh P.-R. |
| 臺大學術典藏 |
2020-06-27T06:40:23Z |
Characterization of a novel allergen, a major IgE-binding protein from Aspergillus flavus, as an alkaline serine protease
|
Chiou S.-H.; Lai W.-Y.; BOR-LUEN CHIANG; Chow L.-P.; Yu C.-J.;Chiou S.-H.;Lai W.-Y.;Bor-Luen Chiang;Chow L.-P.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-27T06:40:23Z |
Identification and expression of Pen c 2, a novel allergen from Penicillium citrinum
|
Su N.-Y.; Yu C.-J.; BOR-LUEN CHIANG; Shen H.-D.; Chow L.-P.; Chow L.-P.;Su N.-Y.;Yu C.-J.;Bor-Luen Chiang;Shen H.-D. |
| 臺大學術典藏 |
2020-06-27T06:40:21Z |
Characterization of Pen n 13, a major allergen from the mold Penicillium notatum
|
Chow L.-P.;Chiou S.-H.;Hsiao M.-C.;Yu C.-J.;Bor-Luen Chiang; Chow L.-P.; Chiou S.-H.; Hsiao M.-C.; Yu C.-J.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2020-06-27T06:40:09Z |
Proteomics and immunological analysis of a novel shrimp allergen, Pen m 2
|
Yu C.-J.;Lin Y.-F.;Bor-Luen Chiang;Chow L.-P.; Yu C.-J.; Lin Y.-F.; BOR-LUEN CHIANG; Chow L.-P. |
| 臺大學術典藏 |
2020-06-27T06:38:50Z |
NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility
|
Wu M.-F.;Shu C.-C.;Wang J.-Y.;Yan B.-S.;Lai H.-C.;Bor-Luen Chiang;Wu L.S.-H.;Yu C.-J.; Wu M.-F.; Shu C.-C.; Wang J.-Y.; Yan B.-S.; Lai H.-C.; BOR-LUEN CHIANG; Wu L.S.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-17T03:01:49Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S. ;Sung-Liang Yu ;Chen H.-Y. ;Hsu Y.-C. ;Su K.-Y. ;Chen H.-W. ;Chen C.-Y. ;Yu C.-J. ;Shih J.-Y. ;Chang Y.-L. ;Cheng C.-L. ;Hsu C.-P. ;Hsia J.-Y. ;Lin C.-Y. ;Wu G. ;Liu C.-H. ;Wang C.-D. ;Yang K.-C. ;Chen Y.-W. ;Lai Y.-L. ;Hsu C.-C. ;Lin T.-C. ;Yang T.-Y. ;Chen K.-C. ;Hsu K.-H. ;Chen J.J.W. ;Chang G.-C. ;Li K.-C. ;Yang P.-C.; Yuan S.; SUNG-LIANG YU; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:38Z |
R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability
|
Chen H.-Y.;Sung-Liang Yu;Ho B.-C.;Su K.-Y.;Hsu Y.-C.;Chang C.-S.;Li Y.-C.;Yang S.-Y.;Hsu P.-Y.;Ho H.;Chang Y.-H.;Chen C.-Y.;Yang H.-I.;Hsu C.-P.;Yang T.-Y.;Chen K.-C.;Hsu K.-H.;Tseng J.-S.;Hsia J.-Y.;Chuang C.-Y.;Yuan S.;Lee M.-H.;Liu C.-H.;Wu G.-I.;Hsiung C.A.;Chen Y.-M.;Wang C.-L.;Huang M.-S.;Yu C.-J.;Chen K.-Y.;Tsai Y.-H.;Su W.-C.;Chen H.-W.;Chen J.J.W.;Chen C.-J.;Chang G.-C.;Yang P.-C.;Li K.-C.; Chen H.-Y.; SUNG-LIANG YU; Ho B.-C.; Su K.-Y.; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; Yu C.-J.; Chen K.-Y.; Tsai Y.-H.; Su W.-C.; Chen H.-W.; Chen J.J.W.; Chen C.-J.; Chang G.-C.; Yang P.-C.; Li K.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:32Z |
SP110b controls host immunity and susceptibility to tuberculosis
|
Leu J.-S.;Chen M.-L.;Chang S.-Y.;Sung-Liang Yu;Lin C.-W.;Wang H.;Chen W.-C.;Chang C.-H.;Wang J.-Y.;Lee L.-N.;Yu C.-J.;Kramnik I.;Yan B.-S.; Leu J.-S.; Chen M.-L.; Chang S.-Y.; SUNG-LIANG YU; Lin C.-W.; Wang H.; Chen W.-C.; Chang C.-H.; Wang J.-Y.; Lee L.-N.; Yu C.-J.; Kramnik I.; Yan B.-S. |
| 臺大學術典藏 |
2020-06-17T03:01:32Z |
Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS
|
Su K.-Y.;Yan B.-S.;Chiu H.-C.;Yu C.-J.;Chang S.-Y.;Jou R.;Liu J.-L.;Hsueh P.-R.;Sung-Liang Yu; Su K.-Y.; Yan B.-S.; Chiu H.-C.; Yu C.-J.; Chang S.-Y.; Jou R.; Liu J.-L.; Hsueh P.-R.; SUNG-LIANG YU |
| 臺大學術典藏 |
2020-06-17T03:01:32Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; Ho C.-C.; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; SUNG-LIANG YU; Liu T.-W.; Chang G.-C.; Tseng C.-H.;Chiang C.-J.;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.H.;Tsai C.-M.;Huang M.-S.;Ho C.-C.;Yu C.-J.;Tsai Y.-H.;Chen J.-S.;Chou T.-Y.;Tsai M.-H.;Chen H.-Y.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Sung-Liang Yu;Liu T.-W.;Chang G.-C.; Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H. |
| 臺大學術典藏 |
2020-06-17T03:01:28Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.;Sung-Liang Yu;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Yu C.-J.;Yang P.-C.;Ho C.-C.; Lin C.-A.; SUNG-LIANG YU; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-06-01T09:06:40Z |
National survey of ABC (A1C, blood pressure, cholesterol) of Diabetes Health Promotion Institutes in Taiwan: 2002–2018
|
Chih-Yuan Wang;Tu S.-T.;Sheu W.H.-H.;Chen I.-C.;Chuang L.-M.;Wu M.-S.;Yu C.-J.; CHIH-YUAN WANG; Tu S.-T.; Sheu W.H.-H.; Chen I.-C.; Chuang L.-M.; Wu M.-S.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-01T03:55:43Z |
Small cell lung cancer and acromegaly: A case report
|
Weng S.-F.;Liao K.-M.;Su D.-H.;Yu C.-J.;Fen-Yu Tseng; Weng S.-F.; Liao K.-M.; Su D.-H.; Yu C.-J.; FEN-YU TSENG |
| 臺大學術典藏 |
2020-06-01T03:55:31Z |
Advanced physical examination training course improves medical students' confidence in physical examination
|
Fen-Yu Tseng;Chang Y.-T.;Yu C.-J.;Chang S.-C.; FEN-YU TSENG; Chang Y.-T.; Yu C.-J.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-01T03:27:13Z |
Performance assessment of the BluePoint MycoID plus kit for identification of Mycobacterium tuberculosis, including rifampin- and isoniazid-resistant isolates, and nontuberculous mycobacteria
|
Hsueh P.-R.;Yu C.-J.;WEI-YIH CHIU;Chang T.-C.;Chien J.-Y.; Chien J.-Y.; Chang T.-C.; WEI-YIH CHIU; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-05-26T09:27:33Z |
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma
|
Chih-Hsin Yang;Cheng A.-L;Yeh K.-H;Yu C.-J;Lin J.-F;Yang P.-C.; CHIH-HSIN YANG; Cheng A.-L; Yeh K.-H; Yu C.-J; Lin J.-F; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H;Chih-Hsin Yang;Yu C.-J;Hsu C;Cheng A.-L;Yang P.-C.; Kuo S.-H; CHIH-HSIN YANG; Yu C.-J; Hsu C; Cheng A.-L; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients
|
Chang G.-C;Tsai C.-M;Chen K.-C;Yu C.-J;Shih J.-Y;Yang T.-Y;Lin C.-P;Hsu J.-Y;Chiu C.-H;Perng R.-P;Yang P.-C;Chih-Hsin Yang; Chang G.-C; Tsai C.-M; Chen K.-C; Yu C.-J; Shih J.-Y; Yang T.-Y; Lin C.-P; Hsu J.-Y; Chiu C.-H; Perng R.-P; Yang P.-C; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y;Gow C.-H;Yu C.-J;Chih-Hsin Yang;Chang Y.-L;Tsai M.-F;Hsu Y.-C;Chen K.-Y;Su W.-P;Yang P.-C.; Shih J.-Y; Gow C.-H; Yu C.-J; CHIH-HSIN YANG; Chang Y.-L; Tsai M.-F; Hsu Y.-C; Chen K.-Y; Su W.-P; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P;Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Hsu C;Yang P.-C.; Su W.-P; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Hsu C; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:26Z |
Revisit of 1997 TNM staging system - Survival analysis of 1112 lung cancer patients in Taiwan
|
Perng R.-P;Chen C.-Y;Chang G.-C;Hsia T.-C;Hsu N.-Y;Tsai Y.-H;Tsai C.-M;Chih-Hsin Yang;Chen Y.-M;Yu C.-J;Lee J.-J;Hsu H.-S;Yu C.-T;Kao E.-L;Chiu C.-H.; Perng R.-P; Chen C.-Y; Chang G.-C; Hsia T.-C; Hsu N.-Y; Tsai Y.-H; Tsai C.-M; CHIH-HSIN YANG; Chen Y.-M; Yu C.-J; Lee J.-J; Hsu H.-S; Yu C.-T; Kao E.-L; Chiu C.-H. |
| 臺大學術典藏 |
2020-05-26T09:27:26Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Chih-Hsin Yang;Shih J.-Y;Chen K.-C;Yu C.-J;Yang T.-Y;Lin C.-P;Su W.-P;Gow C.-H;Hsu C;Chang G.-C;Yang P.-C.; CHIH-HSIN YANG; Shih J.-Y; Chen K.-C; Yu C.-J; Yang T.-Y; Lin C.-P; Su W.-P; Gow C.-H; Hsu C; Chang G.-C; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:25Z |
A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma
|
Chen Y.-M;Yu C.-J;Chih-Hsin Yang;Perng R.-P;Tsai C.-M;Shih J.-F;Cheng A.-L;Lefresne F;Barbier M;Pouget J.-C;Yang P.-C.; Chen Y.-M; Yu C.-J; CHIH-HSIN YANG; Perng R.-P; Tsai C.-M; Shih J.-F; Cheng A.-L; Lefresne F; Barbier M; Pouget J.-C; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:24Z |
Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response
|
Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Kuo S.-H;Chiu Y.-H;Chang Y.-L;Chien C.-R;Gow C.-H; Gow C.-H; Chien C.-R; Chang Y.-L; Chiu Y.-H; Kuo S.-H; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:24Z |
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
|
Bean J;Brennan C;Shih J.-Y;Riely G;Viale A;Wang L;Chitale D;Motoi N;Szoke J;Broderick S;Balak M;Chang W.-C;Yu C.-J;Gazdar A;Pass H;Rusch V;Gerald W;Huang S.-F;Yang P.-C;Miller V;Ladanyi M;Chih-Hsin Yang;Pao W.; Bean J; Brennan C; Shih J.-Y; Riely G; Viale A; Wang L; Chitale D; Motoi N; Szoke J; Broderick S; Balak M; Chang W.-C; Yu C.-J; Gazdar A; Pass H; Rusch V; Gerald W; Huang S.-F; Yang P.-C; Miller V; Ladanyi M; CHIH-HSIN YANG; Pao W. |
| 臺大學術典藏 |
2020-05-26T09:27:23Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:23Z |
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers
|
Chih-Hsin Yang;Shih J.-Y;Hsu C;Yu C.-J;Lo Y;Chen J.-P; Chen J.-P; Lo Y; Yu C.-J; Hsu C; Shih J.-Y; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:22Z |
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma
|
Shih J.-Y; Lee Y.-C; Yang P.-C.; Yang P.-C.;Lee Y.-C;Shih J.-Y;Hsu Y.-C;Chih-Hsin Yang;Chang Y.-L;Yu C.-J;Gow C.-H;Wu S.-G; Wu S.-G; Gow C.-H; Yu C.-J; Chang Y.-L; CHIH-HSIN YANG; Hsu Y.-C |
| 臺大學術典藏 |
2020-05-26T09:27:22Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Kao W.-Y.;Lin Z.-Z;Yu C.-T;Kuo H.-P;Chang W.-C;Yu C.-J;Chung C.-Y;Ho M.-L;Wang J.-L;Huang M.-S;Chen C.-H;Chen H.-C;Hsia T.-C;Tsao C.-J;Su W.-C;Lai R.-S;Chu N.-M;Hsieh R.-K;Lin M.-C;Chang G.-C;Chen Y.-M;Chih-Hsin Yang;Perng R.-P; Perng R.-P; CHIH-HSIN YANG; Chen Y.-M; Chang G.-C; Lin M.-C; Hsieh R.-K; Chu N.-M; Lai R.-S; Su W.-C; Tsao C.-J; Hsia T.-C; Chen H.-C; Chen C.-H; Huang M.-S; Wang J.-L; Ho M.-L; Chung C.-Y; Yu C.-J; Chang W.-C; Kuo H.-P; Yu C.-T; Lin Z.-Z; Kao W.-Y. |
| 臺大學術典藏 |
2020-05-26T09:27:22Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
Yang P.-C.;Pao W;Cheng A.-L;Bean J;Huang C.-L;Shun C.-T;Huang C.-J;Lin Z.-Z;Chen K.-Y;Tsai M.-C;Hu F.-C;Chang Y.-C;Shih J.-Y;Yu C.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Chang Y.-C; Hu F.-C; Tsai M.-C; Chen K.-Y; Lin Z.-Z; Huang C.-J; Shun C.-T; Huang C.-L; Bean J; Cheng A.-L; Pao W; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Lin C.-C; Huang T.-C; Yang P.-C; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Cheng A.-L; Hu F.-C; Kuo S.-H; Hsu C; Chih-Hsin Yang;Yang P.-C;Huang T.-C;Lin C.-C;Yu C.-J;Shih J.-Y;Cheng A.-L;Hu F.-C;Kuo S.-H;Hsu C |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:19Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
Huang C.-L; CHIH-HSIN YANG; Yeh K.-H; Hu F.-C; Chen K.-Y; Shih J.-Y; Lin Z.-Z; Yu C.-J; Cheng A.-L; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:19Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H; Chang Y.-L; Hsu Y.-C; Tsai M.-F; Wu C.-T; Yu C.-J; CHIH-HSIN YANG; Lee Y.-C; Yang P.-C; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-26T09:27:18Z |
Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors
|
Yang P.-C.; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y; Chen J.-H; Chen K.-Y; Chen K.-Y;Chen J.-H;Shih J.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:18Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y;Shih J.-Y;Chih-Hsin Yang;Chen K.-Y;Ho C.-C;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; CHIH-HSIN YANG; Chen K.-Y; Ho C.-C; Yu C.-J; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:18Z |
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors
|
Lin C.-C;Hsu H.-H;Sun C.-T;Shih J.-Y;Lin Z.-Z;Yu C.-J;Chen G.G;Hsin M.K.Y;Lam K.C;Leung L;Chih-Hsin Yang;Mok T.; Lin C.-C; Hsu H.-H; Sun C.-T; Shih J.-Y; Lin Z.-Z; Yu C.-J; Chen G.G; Hsin M.K.Y; Lam K.C; Leung L; CHIH-HSIN YANG; Mok T. |
| 臺大學術典藏 |
2020-05-26T09:27:18Z |
Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer
|
Lee J.-H;Yu C.-J;Chen K.-Y;Shih J.-Y;Lin Y.-L;Chih-Hsin Yang; Lee J.-H; Yu C.-J; Chen K.-Y; Shih J.-Y; Lin Y.-L; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:16Z |
Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer
|
Shih J.-Y; Chang S.-H; Yu C.-J; Hsu Y.-C; CHIH-HSIN YANG; Wu J.-Y; Wu J.-Y;Chih-Hsin Yang;Hsu Y.-C;Yu C.-J;Chang S.-H;Shih J.-Y;Yang P.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:16Z |
Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer
|
Wu J.-Y;Yu C.-J;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Wu J.-Y; Yu C.-J; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:12Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
CHIH-HSIN YANG; Yu C.-J; Lee J.-H; Hsu Y.-C; Chang Y.-L; Shih J.-Y; Yang P.-C.; Wu S.-G;Chih-Hsin Yang;Yu C.-J;Lee J.-H;Hsu Y.-C;Chang Y.-L;Shih J.-Y;Yang P.-C.; Wu S.-G |
| 臺大學術典藏 |
2020-05-26T09:27:12Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:12Z |
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer
|
Wu J.-Y;Yu C.-J;Chang Y.-C;Chih-Hsin Yang;Shih J.-Y;Yang P.-C.; Wu J.-Y; Yu C.-J; Chang Y.-C; CHIH-HSIN YANG; Shih J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:11Z |
Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed
|
Chen C.-Y;Chang Y.-L;Shih J.-Y;Lin J.-W;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Chen C.-Y; Chang Y.-L; Shih J.-Y; Lin J.-W; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C. |
Showing items 1581-1630 of 2308 (47 Page(s) Totally)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
View [10|25|50] records per page
